Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil add-on to alpha1 blockers in Japanese men with BPH
NCT02431754Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tadalafil in benign prostatic hyperplasia (BPH), sponsored by Eli Lilly and Company. Started Apr 2015; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02431754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431754.